HMGA2 as a Critical Regulator in Cancer Development
Top Cited Papers
Open Access
- 13 February 2021
- Vol. 12 (2), 269
- https://doi.org/10.3390/genes12020269
Abstract
The high mobility group protein 2 (HMGA2) regulates gene expression by binding to AT-rich regions of DNA. Akin to other DNA architectural proteins, HMGA2 is highly expressed in embryonic stem cells during embryogenesis, while its expression is more limited at later stages of development and in adulthood. Importantly, HMGA2 is re-expressed in nearly all human malignancies, where it promotes tumorigenesis by multiple mechanisms. HMGA2 increases cancer cell proliferation by promoting cell cycle entry and inhibition of apoptosis. In addition, HMGA2 influences different DNA repair mechanisms and promotes epithelial-to-mesenchymal transition by activating signaling via the MAPK/ERK, TGFβ/Smad, PI3K/AKT/mTOR, NFkB, and STAT3 pathways. Moreover, HMGA2 supports a cancer stem cell phenotype and renders cancer cells resistant to chemotherapeutic agents. In this review, we discuss these oncogenic roles of HMGA2 in different types of cancers and propose that HMGA2 may be used for cancer diagnostic, prognostic, and therapeutic purposes.This publication has 189 references indexed in Scilit:
- Regulation of Transcription Factor Twist Expression by the DNA Architectural Protein High Mobility Group A2 during Epithelial-to-Mesenchymal TransitionJournal of Biological Chemistry, 2012
- Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancerThe EMBO Journal, 2011
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyNature Genetics, 2010
- Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerProceedings of the National Academy of Sciences of the United States of America, 2009
- FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating AktCancer Cell, 2009
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphomaNature, 2009
- Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7The EMBO Journal, 2009
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasionProceedings of the National Academy of Sciences of the United States of America, 2007
- Cell Death: Critical Control PointsCell, 2004